Bone mineral density and parathyroid function in patients on maintenance hemodialysis

International Urology and Nephrology

Volumn 43, Issue 1, 2011, Pages 191-201

  Ambrus, Cs ^a,b   Almasi, Cs ^a   Berta, K ^a   Deak, Gy ^a   Marton, A ^a   Molnar, M Zs ^a   Nemeth, Zs ^a   Horvath, Cs ^a   Lakatos, P ^a   Szathmari, M ^a   Mucsi, I ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Bone mineral density; Bone turnover markers; Hemodialysis; Metabolic bone diseases; Renal osteodystrophy

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; CALCITRIOL; CALCIUM CARBONATE; CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN TYPE 1; MAGNESIUM OXIDE; PHOSPHATE BINDING AGENT; SEVELAMER;

ADULT; ARTICLE; BLOOD SAMPLING; BONE DENSITOMETRY; BONE DENSITY; BONE METABOLISM; BONE TURNOVER; CAUCASIAN; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; HEMODIALYSIS PATIENT; HUMAN; HYPOPARATHYROIDISM; KIDNEY FAILURE; LABORATORY TEST; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; PARATHYROID FUNCTION; RADIUS;

ABSORPTIOMETRY, PHOTON; BONE DENSITY; BONE DISEASES, METABOLIC; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HUNGARY; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; PARATHYROID HORMONE; RENAL DIALYSIS; RISK FACTORS;

EID: 79953816996     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-009-9702-2     Document Type: Article

References (47)

1. Moe SM et al (2007) Chronic kidney disease-mineral-bone disorder: a new paradigm. Adv Chronic Kidney Dis 14(1):3-12 (Pubitemid 46014534)
2. Moe S et al (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int 69(11):1945-1953 (Pubitemid 43924257)
3. Johansen KL, Chertow GM (2007) Chronic kidney disease mineral bone disorder and health-related quality of life among incident end-stage renal-disease patients. J Ren Nutr 17(5):305-313 (Pubitemid 47284912)
4. Mittalhenkle A, Gillen DL, Stehman-Breen CO (2004) Increased risk of mortality associated with hip fracture in the dialysis population. Am J Kidney Dis 44(4):672-679 (Pubitemid 39237611)
5. Toussaint ND et al (2008) Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease. Nephrol Dial Transplant 23(2): 586-593 (Pubitemid 351767633)
6. Ersoy FF (2007) Osteoporosis in the elderly with chronic kidney disease. Int Urol Nephrol 39(1):321-331
7. Alem AM et al (2000) Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int 58(1):396-399 (Pubitemid 30429887)
8. Jadoul M et al (2006) Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the dialysis outcomes and practice patterns study. Kidney Int 70(7):1358-1366 (Pubitemid 44435190)
9. Urena P et al (2003) Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients. Nephrol Dial Transplant 18(11):2325-2331 (Pubitemid 37345093)
10. Jamal SA, Hayden JA, Beyene J (2007) Low bone mineral density and fractures in long-term hemodialysis patients: a meta-analysis. Am J Kidney Dis 49(5):674-681 (Pubitemid 46654494)
11. Ersoy FF et al (2006) Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis patients. J Bone Miner Metab 24(1):79-86 (Pubitemid 41821508)
12. Gerakis A et al (2000) Correlation of bone mineral density with the histological findings of renal osteodystrophy in patients on hemodialysis. J Nephrol 13(6):437-443 (Pubitemid 32015745)
13. Jamal SA et al (2002) Bone density and heel ultrasound testing do not identify patients with dialysis-dependent renal failure who have had fractures. Am J Kidney Dis 39(4):843-849 (Pubitemid 34263360)
14. Merino JL et al (2004) Changes in bone mineral density during the first year of dialysis treatment. Int Urol Nephrol 36(2):285-286 (Pubitemid 38961790)
15. Cunningham J et al (2004) Osteoporosis in chronic kidney disease. Am J Kidney Dis 43(3):566-571 (Pubitemid 38298217)
16. Barreto FC et al (2006) Osteoporosis in hemodialysis patients revisited by bone histomorphometry: a new insight into an old problem. Kidney Int 69(10):1852-1857 (Pubitemid 43739215)
17. Martin KJ et al (2004) Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy. Am J Kidney Dis 43(3):558-565 (Pubitemid 38298216)
18. Coco M, Rush H (2000) Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis 36(6):1115-1121
19. Danese MD et al (2006) PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis. Am J Kidney Dis 47(1):149-156 (Pubitemid 41828277)
20. Wang M et al (1995) Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity. Am J Kidney Dis 26(5):836-844
21. Eeckhout E et al (1989) Monitoring of bone mineral content in patients on regular hemodialysis. Nephron 52(2):158-161 (Pubitemid 19134536)
22. Lechleitner P et al (1994) Bone mineral densitometry in dialyzed patients: quantitative computed tomography versus dual photon absorptiometry. Bone 15(4):387-391 (Pubitemid 24168010)
23. Taal MW et al (1999) Risk factors for reduced bone density in haemodialysis patients. Nephrol Dial Transplant 14(8):1922-1928 (Pubitemid 29358889)
24. Kleinbaum DG, Kupper LL, Muller KE, Nizam A (eds) (1998) Applied regression analysis and other multivariable methods, 3rd edn. Duxbury Press, Pacific Grove, pp 281-316
25. Atsumi K et al (1999) Risk factors for vertebral fractures in renal osteodystrophy. Am J Kidney Dis 33(2):287-293 (Pubitemid 29072230)
26. Dolgos S et al (2008) Determinants of bone mass in endstage renal failure patients at the time of kidney transplantation. Clin Transpl 22(4):462-468
27. Guh JY et al (2002) Risk factors and risk for mortality of mild hypoparathyroidism in hemodialysis patients. Am J Kidney Dis 39(6):1245-1254
28. London GM et al (2003) Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transpl 18(9):1731-1740 (Pubitemid 37098542)
29. London GM et al (2004) Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol 15(7):1943-1951 (Pubitemid 38822076)
30. Spasovski GB (2007) Bone health and vascular calcification relationships in chronic kidney disease. Int Urol Nephrol 39(4):1209-1216
31. Torres A et al (1995) Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH. Kidney Int 47(5):1434-1442
32. Hutchison AJ et al (1993) Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease. Kidney Int 44(5):1071-1077 (Pubitemid 23316476)
33. Gerakis A et al (1996) Biochemical markers for noninvasive diagnosis of hyperparathyroid bone disease and adynamic bone in patients on haemodialysis. Nephrol Dial Transpl 11(12):2430-2438 (Pubitemid 27033776)
34. Quarles LD, Lobaugh B, Murphy G (1992) Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia. J Clin Endocrinol Metab 75(1):145-150
35. Monge M et al (2006) Reappraisal of 2003 NKF-K/DOQI guidelines for management of hyperparathyroidism in chronic kidney disease patients. Nat Clin Pract Nephrol 2(6):326-336 (Pubitemid 44058968)
36. Shahapuni I et al (2005) How do calcimimetics fit into the management of parathyroid hormone, calcium, and phosphate disturbances in dialysis patients? Semin Dial 18(3):226-238
37. Fournier A et al (1997) The clinical significance of adynamic bone disease in uremia. Adv Nephrol Necker Hosp 27:131-166
38. Ghazali A et al (1999) Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol? Kidney Int 55(6):2169-2177
39. Jean G et al (2008) Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers. Nephrol Dial Transpl 23(11):3670-3676
40. Ueda M et al (2005) Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH. Life Sci 77(10):1130-1139 (Pubitemid 40835891)
41. Drueke TB (1996) Abnormal skeletal response to parathyroid hormone and the expression of its receptor in chronic uremia. Pediatr Nephrol 10(3):348-350
42. Urena P et al (1996) PTH/PTHrP receptor mRNA is downregulated in epiphyseal cartilage growth plate of uraemic rats. Nephrol Dial Transpl 11(10):2008-2016 (Pubitemid 26345466)
43. Slatopolsky E et al (2000) A novel mechanism for skeletal resistance in uremia. Kidney Int 58(2):753-761 (Pubitemid 30620025)
44. Lehmann G et al (2005) Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry. Kidney Int 68(3): 1206-1214 (Pubitemid 43246438)
45. Sneve M et al (2008) The association between serum parathyroid hormone and bone mineral density, and the impact of smoking: the Tromso study. Eur J Endocrinol 158(3):401-409 (Pubitemid 351405006)
46. Pei Y et al (1993) Renal osteodystrophy in diabetic patients. Kidney Int 44(1):159-164 (Pubitemid 23198039)
47. van Daele PL et al (1995) Bone density in non-insulin-dependent diabetes mellitus. The Rotterdam study. Ann Intern Med 122(6):409-414